Table of Contents
✨ Onyx Summary
Seer, Inc. (Nasdaq: SEER) will participate in the Morgan Stanley 23rd Annual Global Healthcare Conference on September 9, 2025, featuring a fireside chat at 12:20 p.m. ET.
A live webcast and replay will be accessible on the company’s investor website.
On August 26, 2025, Seer announced its participation in the Morgan Stanley 23rd Annual Global Healthcare Conference in New York. A webcast of the September 9 fireside chat will be available on the company’s investor website.
Overview
Dateline: Redwood City, Calif. — August 26, 2025
Seer, Inc. (Nasdaq: SEER) will participate in the Morgan Stanley 23rd Annual Global Healthcare Conference in New York, NY.
Event Details
- Format: Fireside chat
- Date: Tuesday, September 9, 2025
- Time: 12:20 p.m. Eastern Time / 9:20 a.m. Pacific Time
- Location: New York, NY
Fireside chat: Tuesday, September 9, 2025 at 12:20 p.m. ET (9:20 a.m. PT).
Webcast & Replay
A live webcast will be available on the Investor section of Seer’s website at investor.seer.bio. An archived replay will be posted following the conference.
About Seer
Seer, Inc. (Nasdaq: SEER) develops products for deep, unbiased proteomics. The Proteograph Product Suite integrates engineered nanoparticles, automation instrumentation, consumables, and analytical software to deliver proteomic insights at scale. Seer’s products are for research use only and are not intended for diagnostic procedures. Learn more at www.seer.bio.
Media Contact
Consort Partners — pr@seer.bio
Investor Inquiries
Carrie Mendivil — investor@seer.bio
